Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Terminated Phase Trials for Plerixafor (DB06809)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01076270Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment